Profiel
Michel Dreano is the founder of Sonnet BioTherapeutics CH SA and Remedys Foundation.
Prior to this, he worked as CFO, Director & Chief Business Officer at RELIEF THERAPEUTICS Holding SA from 2017 to 2019 and as a Manager-Project & Alliance at Serono International SA. Dr. Dreano holds a doctorate degree from L'Université de Bourgogne and Université Paris Diderot-Paris 7.
Actieve functies van Michel Dreano
| Bedrijven | Functie | Begin |
|---|---|---|
Remedys Foundation | Oprichter | - |
Eerdere bekende functies van Michel Dreano
| Bedrijven | Functie | Einde |
|---|---|---|
| MINDMAZE THERAPEUTICS HOLDING SA | Financieel Directeur/CFO | 26-04-2019 |
Serono International SA | Corporate Officer/Principal | - |
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Manufactures drugs for peripheral neuropathies | Oprichter | - |
Opleiding van Michel Dreano
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
L'Université de Bourgogne
L'Université de Bourgogne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Paris Diderot-Paris 7
Université Paris Diderot-Paris 7 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Serono International SA | |
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Manufactures drugs for peripheral neuropathies | Health Technology |
RELIEF THERAPEUTICS Holding SA
RELIEF THERAPEUTICS Holding SA Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of biopharmaceutical products for respiratory diseases | Health Technology |
Remedys Foundation |
















